Klatte T - Search Results

1

A Decision Analysis Evaluating Screening for Kidney Cancer Using Focused Renal Ultrasound.

Rossi SH, Klatte T, Usher-Smith JA, Fife K, Welsh SJ, Dabestani S, Bex A, Nicol D, Nathan P, Stewart GD, Wilson ECF. Rossi SH, et al. Among authors: klatte t. Eur Urol Focus. 2021 Mar;7(2):407-419. doi: 10.1016/j.euf.2019.09.002. Epub 2019 Sep 14. Eur Urol Focus. 2021. PMID: 31530498

2

High-intensity focused ultrasound for the treatment of renal masses: current status and future potential.

Klatte T, Marberger M. Klatte T, et al. Curr Opin Urol. 2009 Mar;19(2):188-91. doi: 10.1097/MOU.0b013e328323f641. Curr Opin Urol. 2009. PMID: 19188773 Review.

3

Editorial comment.

Klatte T. Klatte T. J Urol. 2009 Dec;182(6):2606. doi: 10.1016/j.juro.2009.08.197. Epub 2009 Oct 17. J Urol. 2009. PMID: 19836796 No abstract available.

4

Renal cell carcinoma of native kidneys in renal transplant patients.

Klatte T, Marberger M. Klatte T, et al. Curr Opin Urol. 2011 Sep;21(5):376-9. doi: 10.1097/MOU.0b013e32834962bf. Curr Opin Urol. 2011. PMID: 21730855 Review.

5

Prospective randomized multicenter study comparing prostate cancer detection rates of end-fire and side-fire transrectal ultrasound probe configuration.

Rom M, Pycha A, Wiunig C, Reissigl A, Waldert M, Klatte T, Remzi M, Seitz C. Rom M, et al. Among authors: klatte t. Urology. 2012 Jul;80(1):15-8. doi: 10.1016/j.urology.2012.01.061. Epub 2012 May 10. Urology. 2012. PMID: 22578920 Clinical Trial.

6

The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation.

Klatte T, Kroeger N, Zimmermann U, Burchardt M, Belldegrun AS, Pantuck AJ. Klatte T, et al. World J Urol. 2014 Jun;32(3):597-605. doi: 10.1007/s00345-014-1284-7. Epub 2014 Apr 4. World J Urol. 2014. PMID: 24700308 Review.

7

Re: cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Klatte T. Klatte T. Eur Urol. 2015 Oct;68(4):737. doi: 10.1016/j.eururo.2015.06.032. Eur Urol. 2015. PMID: 26334120 No abstract available.

8

Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma after Nephrectomy.

Klatte T. Klatte T. Eur Urol. 2017 May;71(5):835-836. doi: 10.1016/j.eururo.2017.01.026. Epub 2017 Jan 28. Eur Urol. 2017. PMID: 28143685 No abstract available.

9

Serum Adiponectin Predicts Cancer-specific Survival of Patients with Renal Cell Carcinoma.

de Martino M, Leitner CV, Hofbauer SL, Lucca I, Haitel A, Shariat SF, Klatte T. de Martino M, et al. Among authors: klatte t. Eur Urol Focus. 2016 Jun;2(2):197-203. doi: 10.1016/j.euf.2015.06.012. Epub 2015 Jul 15. Eur Urol Focus. 2016. PMID: 28723535

10

Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?

Capitanio U, Stewart GD, Klatte T, Akdogan B, Roscigno M, Marszalek M, Dell'Oglio P, Zaffuto E, Rodriguez Faba O, Salagierski M, Lingard J, Carini M, Ouzaid I, Mir MC, Montorsi F, Da Pozzo LF, Stief C, Minervini A, Brookman-May SD. Capitanio U, et al. Among authors: klatte t. Eur Urol Focus. 2018 Dec;4(6):972-977. doi: 10.1016/j.euf.2017.02.020. Epub 2017 Mar 21. Eur Urol Focus. 2018. PMID: 28753867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

362 results

Search Page